Latest Bcal Diagnostics (ASX:BDX) News

Page 4

Page 4 of 4

How BCAL’s New Partnership Could Transform Breast Cancer Screening in Australia

BCAL Diagnostics Accelerates BREASTEST plus™ Adoption with Cancer Care Associates Deal

BCAL Diagnostics has secured a strategic partnership with Cancer Care Associates to fast-track the clinical adoption and revenue generation of its innovative BREASTEST plus™ breast cancer blood test starting FY2026.

Ada Torres

3 July 2025

BCAL Diagnostics Nears BREASTEST® Launch with Key Milestones and $7M Cash Buffer

BCAL Diagnostics is poised to launch its innovative BREASTEST® breast cancer diagnostic test in early 2025, backed by recent NATA accreditation, patent acceptance, and a $2.6 million R&D tax offset.

Ada Torres

31 Jan 2025